Drug middlemen, also known as PBMs, are accused of making false statements during congressional testimony last month as part of an investigation into the practices of these entities.
House Oversight Chair James Comer (R-Ky.) wrote to CVS, UnitedHealth, and Cigna late last month asking them to correct remarks they made during a July hearing that they don’t steer patients to their own pharmacies or pay them more favorable rates.
Comer said those statements contradicted evidence unearthed by his committee and the Federal Trade Commission, which is independently investigating PBMs.
A Cigna’s Express Scripts unit spokesperson said the company stands behind the testimony and rebuts the letter’s allegations.
